Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

224 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Remarkable Clinical Response of ALK-Rearranged/TP53-Mutant Lung Adenocarcinoma with Liver Metastasis to Atezolizumab-Bevacizumab-Carboplatin-Paclitaxel After ALK Inhibitors: A Case Report.
Iso H, Miyanaga A, Kadoma N, Shinbu K, Tozuka T, Murata A, Nishima S, Sato Y, Nakamichi S, Matsumoto M, Noro R, Terasaki Y, Kubota K, Seike M. Iso H, et al. Among authors: terasaki y. Onco Targets Ther. 2023 Jun 23;16:465-470. doi: 10.2147/OTT.S404035. eCollection 2023. Onco Targets Ther. 2023. PMID: 37384219 Free PMC article.
A case of interstitial lung disease with alveolar hemorrhage induced by pembrolizumab.
Sugano T, Seike M, Noro R, Kaburaki S, Tozuka T, Takahashi A, Takano N, Tanaka T, Kashiwada T, Takeuchi S, Minegishi Y, Saito Y, Kubota K, Terasaki Y, Gemma A. Sugano T, et al. Among authors: terasaki y. Onco Targets Ther. 2018 Sep 17;11:5879-5883. doi: 10.2147/OTT.S169321. eCollection 2018. Onco Targets Ther. 2018. PMID: 30271171 Free PMC article.
Immune checkpoint inhibitor-associated interstitial lung diseases correlate with better prognosis in patients with advanced non-small-cell lung cancer.
Sugano T, Seike M, Saito Y, Kashiwada T, Terasaki Y, Takano N, Hisakane K, Takahashi S, Tanaka T, Takeuchi S, Miyanaga A, Minegishi Y, Noro R, Kubota K, Gemma A. Sugano T, et al. Among authors: terasaki y. Thorac Cancer. 2020 Apr;11(4):1052-1060. doi: 10.1111/1759-7714.13364. Epub 2020 Feb 25. Thorac Cancer. 2020. PMID: 32096610 Free PMC article.
Successful Treatment with Afatinib after Osimertinib-induced Interstitial Lung Disease in a Patient with EGFR-mutant Non-small-cell Lung Cancer.
Nishima S, Miyanaga A, Saito S, Yuasa M, Takahashi S, Kashiwada T, Sugano T, Noro R, Minegishi Y, Terasaki Y, Saito Y, Kubota K, Seike M, Gemma A. Nishima S, et al. Among authors: terasaki y. Intern Med. 2021 Feb 15;60(4):591-594. doi: 10.2169/internalmedicine.5435-20. Epub 2020 Sep 30. Intern Med. 2021. PMID: 32999231 Free PMC article.
Efficacy with Trastuzumab Deruxtecan for Non-Small-Cell Lung Cancer Harboring HER2 Exon 20 Insertion Mutation in a Patient with a Poor Performance Status: A Case Report.
Kato Y, Kato Y, Minegishi Y, Suzuki T, Nakamichi S, Matsumoto M, Miyanaga A, Noro R, Kubota K, Terasaki Y, Seike M, Gemma A. Kato Y, et al. Among authors: terasaki y. Onco Targets Ther. 2021 Nov 23;14:5315-5319. doi: 10.2147/OTT.S341290. eCollection 2021. Onco Targets Ther. 2021. PMID: 34848974 Free PMC article.
224 results